1. Home
  2. LIXT vs ANGH Comparison

LIXT vs ANGH Comparison

Compare LIXT & ANGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lixte Biotechnology Holdings Inc.

LIXT

Lixte Biotechnology Holdings Inc.

N/A

Current Price

$2.88

Market Cap

26.5M

Sector

Health Care

ML Signal

N/A

Logo Anghami Inc.

ANGH

Anghami Inc.

N/A

Current Price

$3.72

Market Cap

25.4M

ML Signal

N/A

Company Overview

Basic Information
Metric
LIXT
ANGH
Founded
2005
2012
Country
United States
United Arab Emirates
Employees
3
186
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
26.5M
25.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LIXT
ANGH
Price
$2.88
$3.72
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
41.6K
3.4K
Earning Date
05-11-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$0.25
52 Week High
$6.09
$7.05

Technical Indicators

Market Signals
Indicator
LIXT
ANGH
Relative Strength Index (RSI) 48.07 56.58
Support Level $2.50 $2.83
Resistance Level $3.30 $5.27
Average True Range (ATR) 0.24 0.27
MACD 0.03 0.02
Stochastic Oscillator 51.56 68.46

Price Performance

Historical Comparison
LIXT
ANGH

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About ANGH Anghami Inc.

Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with a catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner Music. It generates the majority of its revenue from subscriptions.

Share on Social Networks: